» Articles » PMID: 37315023

Clinical Epidemiology of COVID-19 Among Hospitalized Children in Rural Western Kenya

Abstract

The epidemiology of pediatric COVID-19 in sub-Saharan Africa and the role of fecal-oral transmission in SARS-CoV-2 are poorly understood. Among children and adolescents in Kenya, we identify correlates of COVID-19 infection, document the clinical outcomes of infection, and evaluate the prevalence and viability of SARS-CoV-2 in stool. We recruited a prospective cohort of hospitalized children aged two months to 15 years in western Kenya between March 1 and June 30 2021. Children with SARS-CoV-2 were followed monthly for 180-days after hospital discharge. Bivariable logistic regression analysis was used to identify the clinical and sociodemographics correlates of SARS-CoV-2 infection. We also calculated the prevalence of SARS-CoV-2 detection in stool of confirmed cases. Of 355 systematically tested children, 55 (15.5%) were positive and were included in the cohort. The commonest clinical features among COVID-19 cases were fever (42/55, 76%), cough (19/55, 35%), nausea and vomiting (19/55, 35%), and lethargy (19/55, 35%). There were no statistically significant difference in baseline sociodemographic and clinical characteristics between SARS-CoV-2 positive and negative participants. Among positive participants, 8/55 (14.5%, 95%CI: 5.3%-23.9%) died; seven during the inpatient period. Forty-nine children with COVID-19 had stool samples or rectal swabs available at baseline, 9 (17%) had PCR-positive stool or rectal swabs, but none had SARS-CoV-2 detected by culture. Syndromic identification of COVID-19 is particularly challenging among children as the presenting symptoms and signs mirror other common pediatric diseases. Mortality among children hospitalized with COVID-19 was high in this cohort but was comparable to mortality seen with other common illnesses in this setting. Among this small set of children with COVID-19 we detected SARS-CoV-2 DNA, but were not able to culture viable SARs-CoV-2 virus, in stool. This suggests that fecal transmission may not be a substantial risk in children recently diagnosed and hospitalized with COVID-19 infection.

References
1.
Liguoro I, Pilotto C, Bonanni M, Ferrari M, Pusiol A, Nocerino A . SARS-COV-2 infection in children and newborns: a systematic review. Eur J Pediatr. 2020; 179(7):1029-1046. PMC: 7234446. DOI: 10.1007/s00431-020-03684-7. View

2.
Effenberger M, Grabherr F, Mayr L, Schwaerzler J, Nairz M, Seifert M . Faecal calprotectin indicates intestinal inflammation in COVID-19. Gut. 2020; 69(8):1543-1544. PMC: 7211078. DOI: 10.1136/gutjnl-2020-321388. View

3.
Yang D, Perbtani Y, Loeb J, Liu N, Draganov P, Estores D . Detection of SARS-CoV-2 in the gastrointestinal tract among patients with negative nasopharyngeal COVID-19 testing prior to endoscopy. Endosc Int Open. 2021; 9(8):E1276-E1282. PMC: 8383081. DOI: 10.1055/a-1490-9234. View

4.
Guo M, Tao W, Flavell R, Zhu S . Potential intestinal infection and faecal-oral transmission of SARS-CoV-2. Nat Rev Gastroenterol Hepatol. 2021; 18(4):269-283. PMC: 7883337. DOI: 10.1038/s41575-021-00416-6. View

5.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View